Laboratorio Reig Jofre, S.A. (RJF.MC)
EUR 2.97
(4.95%)
EUR 2.97
(4.95%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 61.85 Million EUR | 28.36% |
| 2022 | 48.19 Million EUR | 1.16% |
| 2021 | 47.63 Million EUR | 17.99% |
| 2020 | 40.37 Million EUR | 5.36% |
| 2019 | 38.32 Million EUR | 11.3% |
| 2018 | 34.43 Million EUR | 25.16% |
| 2017 | 27.5 Million EUR | -16.66% |
| 2016 | 33 Million EUR | 32.6% |
| 2015 | 24.89 Million EUR | 4.42% |
| 2014 | 23.83 Million EUR | 826.17% |
| 2013 | 2.57 Million EUR | -7.61% |
| 2012 | 2.78 Million EUR | 18.91% |
| 2011 | 2.34 Million EUR | -54.61% |
| 2010 | 5.16 Million EUR | 11.08% |
| 2009 | 4.64 Million EUR | -87.09% |
| 2008 | 36 Million EUR | -10.68% |
| 2007 | 40.31 Million EUR | 16.97% |
| 2006 | 34.46 Million EUR | 6.69% |
| 2005 | 32.3 Million EUR | 231.11% |
| 2004 | 9.75 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 65 Million EUR | 5.08% |
| 2024 Q3 | 66.68 Million EUR | -6.85% |
| 2024 Q2 | 71.59 Million EUR | 10.13% |
| 2023 Q3 | 56.04 Million EUR | -8.28% |
| 2023 Q4 | 61.85 Million EUR | 10.38% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 FY | 61.85 Million EUR | 28.36% |
| 2023 Q2 | 61.1 Million EUR | 0.0% |
| 2022 Q4 | 48.19 Million EUR | -4.6% |
| 2022 FY | 48.19 Million EUR | 1.16% |
| 2022 Q3 | 50.51 Million EUR | 0.8% |
| 2022 Q2 | 50.11 Million EUR | 0.0% |
| 2021 Q2 | 47.14 Million EUR | 21.79% |
| 2021 Q1 | 38.7 Million EUR | -4.13% |
| 2021 FY | 47.63 Million EUR | 17.99% |
| 2021 Q4 | 47.63 Million EUR | 2.23% |
| 2021 Q3 | 46.6 Million EUR | -1.14% |
| 2020 Q2 | 43.77 Million EUR | 17.22% |
| 2020 Q4 | 40.37 Million EUR | -1.18% |
| 2020 Q3 | 40.85 Million EUR | -6.68% |
| 2020 FY | 40.37 Million EUR | 5.36% |
| 2020 Q1 | 37.34 Million EUR | -2.54% |
| 2019 Q2 | 34.97 Million EUR | 0.97% |
| 2019 Q4 | 38.32 Million EUR | 15.51% |
| 2019 FY | 38.32 Million EUR | 11.3% |
| 2019 Q1 | 34.63 Million EUR | 0.6% |
| 2019 Q3 | 33.17 Million EUR | -5.15% |
| 2018 Q3 | 32.73 Million EUR | 4.75% |
| 2018 Q1 | 26.35 Million EUR | -4.2% |
| 2018 FY | 34.43 Million EUR | 25.16% |
| 2018 Q4 | 34.43 Million EUR | 5.19% |
| 2018 Q2 | 31.24 Million EUR | 18.56% |
| 2017 Q1 | 30.79 Million EUR | -6.72% |
| 2017 FY | 27.5 Million EUR | -16.66% |
| 2017 Q2 | 28.82 Million EUR | -6.39% |
| 2017 Q4 | 27.5 Million EUR | -7.02% |
| 2017 Q3 | 29.58 Million EUR | 2.64% |
| 2016 Q4 | 33 Million EUR | 0.38% |
| 2016 FY | 33 Million EUR | 32.6% |
| 2016 Q1 | 23.64 Million EUR | -4.99% |
| 2016 Q2 | 30.11 Million EUR | 27.32% |
| 2016 Q3 | 32.88 Million EUR | 9.2% |
| 2015 Q4 | 24.89 Million EUR | 2.51% |
| 2015 Q3 | 24.28 Million EUR | 0.39% |
| 2015 FY | 24.89 Million EUR | 4.42% |
| 2015 Q2 | 24.19 Million EUR | 13.14% |
| 2015 Q1 | 21.38 Million EUR | -10.31% |
| 2014 Q2 | 2.08 Million EUR | -15.74% |
| 2014 Q3 | 1.91 Million EUR | -8.1% |
| 2014 FY | 23.83 Million EUR | 826.17% |
| 2014 Q4 | 23.83 Million EUR | 1142.94% |
| 2014 Q1 | 2.47 Million EUR | -3.77% |
| 2013 Q2 | 2.93 Million EUR | 9.2% |
| 2013 FY | 2.57 Million EUR | -7.61% |
| 2013 Q4 | 2.57 Million EUR | 4.29% |
| 2013 Q3 | 2.46 Million EUR | -15.85% |
| 2013 Q1 | 2.68 Million EUR | -3.59% |
| 2012 FY | 2.78 Million EUR | 18.91% |
| 2012 Q2 | 2.01 Million EUR | -0.3% |
| 2012 Q3 | 1.77 Million EUR | -11.67% |
| 2012 Q4 | 2.78 Million EUR | 56.6% |
| 2012 Q1 | 2.02 Million EUR | -13.79% |
| 2011 FY | 2.34 Million EUR | -54.61% |
| 2011 Q4 | 2.34 Million EUR | 0.0% |
| 2011 Q2 | 3.67 Million EUR | 0.0% |
| 2010 Q1 | 5.44 Million EUR | 0.0% |
| 2010 FY | 5.16 Million EUR | 11.08% |
| 2010 Q2 | 5.68 Million EUR | 4.3% |
| 2009 FY | 4.64 Million EUR | -87.09% |
| 2008 FY | 36 Million EUR | -10.68% |
| 2007 FY | 40.31 Million EUR | 16.97% |
| 2006 FY | 34.46 Million EUR | 6.69% |
| 2005 FY | 32.3 Million EUR | 231.11% |
| 2004 FY | 9.75 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Almirall, S.A. | 167.37 Million EUR | 63.041% |
| Faes Farma, S.A. | 128.65 Million EUR | 51.92% |